Minimally invasive implantable neurostimulation system

US9931107B2 · kind B2 · utility

Assignee

• Medtronic, Inc. · US

Inventors

• Brad C. Tischendorf · Minneapolis, US
• Eric H. Bonde · Minnetonka, US
• Phillip C. Falkner · Minneapolis, US
• John E. Kast · Hugo, US
• Randy S. Roles · Elk River, US
• Erik R. Scott · Maple Grove, US
• Todd V. Smith · Shoreview, US
• Xuan K. Wei · Plymouth, US
• Anthony M. Chasensky · Okabena, US
• Michael J. Ebert · Fridley, US
• Shawn C. Kelley · Shoreview, US
• Gabriela C. Molnar · Blaine, US
• Richard T. Stone · Minneapolis, US

Key dates

• Filing date: Dec 6, 2013
• Grant date: Apr 3, 2018
• Expiry date: Aug 2, 2036

Classification

• Technology area (CPC F): Mechanical Engineering; Lighting; Heating
• CPC primary: F04C2270/0421
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.